LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 1235 | 4809 | 4126 | 1.1654 | 1.1840 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1235 | 4759 | 3974 | 1.1975 | 1.2257 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1235 | 4185 | 4070 | 1.0282 | 1.0326 |
| MCF7 | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1235 | 4596 | 4126 | 1.1138 | 1.1278 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1235 | 4997 | 3974 | 1.2574 | 1.2911 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1235 | 3864 | 4070 | 0.9493 | 0.9404 |
| MCF7 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1235 | 4732 | 4126 | 1.1468 | 1.1638 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1235 | 4820 | 3974 | 1.2128 | 1.2426 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1235 | 4237 | 4070 | 1.0409 | 1.0472 |
| MCF7 | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1235 | 4667 | 4126 | 1.1310 | 1.1467 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 1235 | 4682 | 3974 | 1.1781 | 1.2043 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 1235 | 4237 | 4070 | 1.0409 | 1.0472 |
| MCF7 | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 1235 | 4350 | 4126 | 1.0542 | 1.0616 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 1235 | 3650 | 3974 | 0.9184 | 0.9016 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 1235 | 2972 | 4070 | 0.7302 | 0.6658 |
| MCF7 | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 1235 | 3711 | 4126 | 0.8993 | 0.8817 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 1235 | 4323 | 4119 | 1.0495 | 1.0564 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 1235 | 4671 | 4356 | 1.0722 | 1.0782 |
| MCF7 | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 1235 | 4390 | 4326 | 1.0147 | 1.0162 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 1235 | 4322 | 4119 | 1.0492 | 1.0561 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 2 | N17 | 72 | hr | 1235 | 4417 | 4356 | 1.0139 | 1.0153 |
| MCF7 | Nilotinib | 0.12 | uM | LJP5 | 3 | N17 | 72 | hr | 1235 | 4583 | 4326 | 1.0593 | 1.0647 |
| MCF7 | Nilotinib | 0.37 | uM | LJP5 | 1 | N16 | 72 | hr | 1235 | 3762 | 4119 | 0.9133 | 0.8983 |
| MCF7 | Nilotinib | 0.37 | uM | LJP5 | 2 | N16 | 72 | hr | 1235 | 4513 | 4356 | 1.0360 | 1.0393 |
| MCF7 | Nilotinib | 0.37 | uM | LJP5 | 3 | N16 | 72 | hr | 1235 | 4495 | 4326 | 1.0390 | 1.0427 |